Drug Topics
OCTOBER 24, 2023
A study published in Primary Care Diabetes pinpoints those at most risk and recommends education to improve the quality of life in diagnosed elderly patients.
PharmaVoice
OCTOBER 24, 2023
Pfizer brought in a new approval for a five-in-one shot for meningococcal disease, and the company has built a sizable vaccine business over time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 24, 2023
Stephen L. Foster, PharmD, FAPhA, FNAP, discussed the new vaccine and RSV prevalence at the National Community Pharmacists Association 2023 Convention and Expo.
Pharmacy Times
OCTOBER 24, 2023
Nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) is a monoclonal antibody approved to prevent against respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants under 8 months of age born during or entering their first RSV season.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 24, 2023
A review published in General Hospital Psychiatry shows large, negative impacts on menopausal women.
Pharmacy Times
OCTOBER 24, 2023
Jack Mozloom, vice president of Public Affairs at the National Community Pharmacists Association (NCPA), speaks with Matt Seiler, general counsel at NCPA, about the current PBM litigation at the 2023 NCPA Convention.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 24, 2023
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as a high tech fashion accessory, but also as a way for people to track their own health and fitness. It has evolved as a popular cardio tool for such uses as heart rate monitoring, recording your ECG, and measuring the oxygen saturation of your blood. But now, after nearly a decade of development, the Apple Watch is being leveraged on an entirely new health frontier: Parkinson’s disease, the degenerative brain dis
Pharmacy Times
OCTOBER 24, 2023
Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.
STAT
OCTOBER 24, 2023
The Centers for Disease Control and Prevention has recommended rationing an important monoclonal antibody product to protect young infants from RSV due to strained supply of the new product, Sanofi’s Beyfortus. In a health alert issued Monday, the CDC said clinicians should prioritize available doses for babies at highest risk from respiratory syncytial virus, reserving 100-milligram doses for infants under the age of 6 months and those with underlying health conditions that put them at h
Pharmacy Times
OCTOBER 24, 2023
mRNA-1083 is an investigational combination vaccine designed to prevent influenza and COVID-19.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 24, 2023
People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. AstraZeneca, which makes the vaccine FluMist, announced Tuesday it has submitted to the Food and Drug Administration a supplemental biologics license application that would allow for self-administration of the vaccine by people ages 18 through 49, and would allow people 18 and older to give the vaccine to eligible children.
Pharmacy Times
OCTOBER 24, 2023
Oncology leaders and pharma representatives discuss collaboration best practices.
STAT
OCTOBER 24, 2023
Infertility has a new definition in the U.S. — one that could make a big difference to would-be parents who are single or LGBTQ+. Last week, the American Society for Reproductive Medicine (ASRM) issued an expanded description of the condition, stating that infertility involves “the need for medical intervention, including, but not limited to, the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as an individual or with a partner.
Fierce Healthcare
OCTOBER 24, 2023
Healthcare’s days of widespread contract labor reliance may be over, but hospitals and health systems are still frequently reporting labor shortages and other operating hurdles keeping them from he | Contract labor reliance may be largely in the past, but hospital leaders say there's still plenty of hurdles ensuring “a slow climb" to long-term operational sustainability.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 24, 2023
Recently, dementia villages have gained popularity in Europe and Australia as an all-in-one solution to caring for and improving the lives of those with Alzheimer’s disease and dementia. The New York Times has reported that it looks like the “future of home care.” Dementia villages are small-scale communities that offer shared housing, minor medical care, and psychosocial support in a neighborhood setting.
Pharmacy Times
OCTOBER 24, 2023
Risk of long COVID was 3 times higher in those who had pre-existing conditions and a short sleep duration, compared to those with no pre-existing conditions and adequate sleep.
STAT
OCTOBER 24, 2023
MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting , a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates. The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the co
Pharmacy Times
OCTOBER 24, 2023
The novel combination met the co-primary endpoints of progression-free survival and overall survival during the CheckMate -901 trial, also demonstrating sizeable improvement in objective response.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 24, 2023
In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers — committed to reducing the U.S. list price of insulin, a drug that millions of people require to live. Following two decades of sharp increases for consumers, the companies vowed to cut insulin prices for some insulins by at least 70%, meaning many people could see their insulin costs capped at $35 a month in the near future.
Fierce Healthcare
OCTOBER 24, 2023
Teladoc's third-quarter revenue grew 8% to reach $660 million, boosted by solid performance in its chronic condition management business and steady membership growth as the company now touts 90 mil | Teladoc's scale, strong financial position and free cash flow performance put the company in a competitive position compared to many virtual care startups struggling in the current macroeconomic environment, executives said.
STAT
OCTOBER 24, 2023
Earlier this month, the U.K. government issued a proposal to gather information and opinions about payments that drug and device makers give to the medical community. The move came amid ongoing concern over financial ties between companies and health care professionals, an issue that has largely been left to trade groups to police. In an effort to take greater control, the government plans to create what resembles the OpenPayments database in the U.S., which emerged from scandals and probes into
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. Having been valued at $27.04 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022.
Pharmaceutical Technology
OCTOBER 24, 2023
SpeechDx will contain recorded voice samples and other data, which will be used to develop algorithms for creating new speech biomarkers.
Fierce Healthcare
OCTOBER 24, 2023
The Center for Medicare and Medicaid Innovation (CMMI) unveiled 2022 calendar year results for the Direct Contracting Model on Monday. | More than three-quarters of those who participated in the program reaped savings, data from CMMI revealed.
pharmaphorum
OCTOBER 24, 2023
Creating behavioural change through incremental, small steps Mike.
STAT
OCTOBER 24, 2023
A new biotech has raised $245 million to test a new asthma medication that could compete with one sold by Amgen and AstraZeneca. The startup, Aiolos Therapeutics, was founded by former Genentech colleagues Khurem Farooq and Tony Adamis after they stumbled upon a drug being developed by Chinese pharma company Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Fierce Healthcare
OCTOBER 24, 2023
UnitedHealthcare is expanding its footprint on the Affordable Care Act (ACA) exchanges to four new states in 2024, the insurance giant
pharmaphorum
OCTOBER 24, 2023
ESMO: Survival data mars Pluvicto prostate cancer trial Phil.
Fierce Healthcare
OCTOBER 24, 2023
Several independent pharmacies have filed suit against pharmacy benefit management giant Express Scripts, alleging that the company colluded with Prime Therapeutics to fix reimbursement rates. | Several independent pharmacies have filed suit against pharmacy benefit management giant Express Scripts, alleging that the company colluded with Prime Therapeutics to fix reimbursement rates.
pharmaphorum
OCTOBER 24, 2023
ESMO: Can BioNTech’s revved-up CAR-T hit solid tumours? Phil.
Drug Store News
OCTOBER 24, 2023
Actress Dara Reneé is partnering with the brand to share how she cares for her signature curls while encouraging others to share their own #PanteneHair journey.
pharmaphorum
OCTOBER 24, 2023
AZ seeks FDA okay for first self-administered flu vaccine Phil.
Fierce Healthcare
OCTOBER 24, 2023
Editor's note: Updated at 12:15 p.m. Oct. 24 with commentary from HCA Healthcare's Q3 earnings call. | The for-profit system celebrated "continued solid demand for our services" during its Q3 2023 earnings call, but had to defend its decisions surrounding Valesco Physician Services to analysts and investors.
Expert insights. Personalized for you.
522 
Let's personalize your content